lentiGuide-Puro.3xBsmBI Citations (2)

Originally described in: CRISPR/Cas9 screening using unique molecular identifiers.
Schmierer B, Botla SK, Zhang J, Turunen M, Kivioja T, Taipale J Mol Syst Biol. 2017 Oct 9;13(10):945. doi: 10.15252/msb.20177834. PubMed Journal

---

Articles Citing lentiGuide-Puro.3xBsmBI

Articles
Network-based elucidation of colon cancer drug resistance mechanisms by phosphoproteomic time-series analysis. Rosenberger G, Li W, Turunen M, He J, Subramaniam PS, Pampou S, Griffin AT, Karan C, Kerwin P, Murray D, Honig B, Liu Y, Califano A. Nat Commun. 2024 May 9;15(1):3909. doi: 10.1038/s41467-024-47957-3. PubMed
A large-scale sORF screen identifies putative microproteins involved in cancer cell fitness. Schlesinger D, Dirks C, Navarro C, Lafranchi L, Spinner A, Raja GL, Mun-Sum Tong G, Eirich J, Martinez TF, Elsasser SJ. iScience. 2025 Jan 23;28(3):111884. doi: 10.1016/j.isci.2025.111884. eCollection 2025 Mar 21. PubMed

If you have published an article using this material, please email us at to have your article added to this page.